About
Science
Pipeline
Investors & Media
FAQs
Contact
Investors & Media
All
Articles
Press Releases
Publications & Presentations
All
Articles
Press Releases
Publications & Presentations
Press Releases
Immusoft to Present at the International Conference on Lymphocyte Engineering 2019
September 10, 2019
Immusoft
Press Releases
Immusoft Announces the Appointment of Robert Hayes, Ph.D. as Chief Scientific Officer
July 17, 2019
Immusoft
Press Releases
Immusoft Raises $20 Million in Series B Financing
January 3, 2019
Immusoft
Press Releases
Immusoft Receives Rare Pediatric Disease Designation for Treatment of MPS I
October 17, 2018
Immusoft
Press Releases
Immusoft Receives $3.5 Million Grant to Expand upon Its Cell Therapy Platform
September 5, 2018
Immusoft
Press Releases
Immusoft Granted Orphan Drug Designation for Treatment of Rare Childhood Disease
May 2, 2018
Immusoft
Press Releases
Immusoft Recognized with “Most Promising Company Award” at Silicon Valley Conference
January 29, 2018
Immusoft
Articles
RetroSense founder Sean Ainsworth named CEO of Seattle biotech
January 28, 2018
Craine's Detroit Business
Previous Page
1
…
3
4
5
